This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 7, 2013

Home   Contact

 


Western Section AUA NEWS YOU NEED NOW



The scientific sessions had high attendance and interest at the 89th Annual Meeting of the Western Section AUA in Monterey.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  What You Wish Your Peers Would Share With You.
BE SURE TO BLOCK THIS OUT AS YOUR LUNCH HOUR THIS DAY BECAUSE YOU DO NOT WANT TO MISS IT.
One hour now will save you three years of anxiety. This webinar will cover topics from Fee for Value to the type of IT capabilities you will need to be successful within the Affordable Care Act.
November 12, 2013
Two convenient times – 11 AM Central and then 11 AM Pacific
Click here to choose your time and register.
 


Iron Status Predicts Type 2 Diabetes Prognosis
Renal & Urology News
Iron status can independently predict long-term outcomes in patients with Type 2 diabetes and coronary artery disease (CAD), according to a study published in Diabetes Care. Dr. Beata Ponikowska from Wroclaw Medical University in Poland, and colleagues measured serum ferritin, transferrin saturation, and soluble transferrin receptor (sTfR) in 287 patients with Type 2 diabetes and stable CAD (average age, 65 years; 78 percent men). Participants were followed for a mean of 45 months.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Penile-Artery Angioplasty Gets Second Look for Erectile Dysfunction
Medscape
A small Taiwanese study is picking up where the ZEN trial left off, testing balloon angioplasty (but not stents) in the penile arteries as a treatment for erectile dysfunction (ED). Presenting the results of the PERFECT-1 trial at TCT 2013 recently, Dr. Tzung-Dau Wang reported that penile-artery angioplasty is a safe and effective treatment for men with ED, producing "clinically durable improvement" in 60 percent of treated patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Few Told About Overdiagnosis From Prostate Cancer Screening
Urology Times
Fewer than 10 percent of patients are being told about the possibility of over-diagnosis and over-treatment as a result of screening for prostate and other cancers, according to findings from a recently published survey. The online survey of 317 U.S. men and women ages 50 to 69 years was designed to determine how many patients had been informed of over-diagnosis and over-treatment by their physicians and how much over-diagnosis they would tolerate when deciding whether to start or continue screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


RA, Erectile Dysfunction Association Seen
The Philippine Star
Men with rheumatoid arthritis had a two-thirds greater risk of developing erectile dysfunction than men without the disease in the first study to show such an association. The odds ratio for prior rheumatoid arthritis in men with erectile dysfunction (ED) was 1.67 that of controls, based on conditional logistic regression analysis, after adjusting for the possible confounding effects of monthly income, geographical location, urbanization level, hypertension, diabetes, coronary heart disease, hyperlipidemia, obesity, and alcohol abuse/ alcohol dependence syndrome.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Humana Issues Positive Coverage Policy for Percutaneous Tibial Nerve Stimulation
Urology Times
Uroplasty announced that Humana, Inc. has written a positive coverage policy for percutaneous tibial nerve stimulation (PTNS) delivered via its Urgent PC Neuromodulation System. Humana is the sixth largest private insurer in the United States, with approximately 8.9 million covered lives in 35 states, and is also the administrator for Tricare South and several Medicare Advantage plans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TOP STORIES


Stage and Grade Dominate RCC Outcomes
mediawireNews
Tumor grade and American Joint Committee on Cancer stage have emerged as the most important predictors of mortality in a competing risks analysis of patients undergoing nephrectomy for renal cell carcinoma (RCC). However, noncancer causes of death had a large impact on patients aged 70 years or older, regardless of tumor grade and stage, reports Maxine Sun.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Robotic Prostate Surgery: Keyhole to the Future
The Sydney Morning Herald
When urologist Justin Vass scrubs in for surgery, he and his team are not alone. These days they are joined by surgical robot, the da Vinci. At first glance, the da Vinci appears like a man-made praying mantis. It comprises a surgeon console, a patient-side cart with four interactive robotic arms and offers 10-times three-dimensional visual magnification.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
The Sacramento Bee
Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement with Huons Co, Ltd., a leading Korean pharmaceuticals company. The agreement formalizes the strategic partnership between the parties and gives Aquavit the worldwide, perpetual, and unlimited license for global commercialization of a cutting-edge drug-delivery system.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Shared Appointments Show Success in Kidney Stone Patients
Urology Times
Among patients with kidney stones, shared medical appointments decrease appointment wait times, increase patient knowledge about stone prevention, and lead to high levels of patient satisfaction, researchers from the University of Wisconsin, Madison reported.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Scoring System Predicts Likelihood of Diabetes Remission After RYGB
Renal & Urology News
Researchers at the Geisinger Health System have developed a simple scoring system (DiaRem) that may help predict which candidates for gastric bypass surgery are likely to achieve Type 2 diabetes remission within five years. Roux-en-Y gastric bypass (RYGB) is currently used to help morbidly obese patients lose weight.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 

WSAUA Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lee Escobedo, Content Editor, 469.420.2663  
Contribute news

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Western Section AUA Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Nov. 7, 2013
Oct. 31, 2013
Oct. 24, 2013
Oct. 18, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063